Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Find effective ways to increase cash back from your credit cards. Boost your rewards and make every purchase count.
23,532 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
As volatility rises and bond yields shift, retirees seek reliable income. Covered call ETFs like XYLD and RYLD offer ...
July 1 brought a sharp move for CoreWeave as a Bloomberg note about Meta expanding into cloud services rattled AI inf...
Cathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
Alphabet stock looks undervalued as the tech giant rides a fresh wave of AI monetization, beating quarterly targets a...
As physical toll climbs for seasoned tradespeople, more are weighing claiming Social Security early. Industry forecas...
Investing in eVTOLs isn’t just about flight tech. The real lever could be charging infrastructure. This guide explain...
Alphabet reports Q2 results after the bell as traders weigh ad growth, AI monetization, and cloud margins. A volatile...
Toll Brothers posted a strong first quarter, underscoring resilience in the luxury segment through disciplined execut...
Suze Orman promotes a staged investing plan for people with large cash cushions, favoring dollar-cost averaging into ...
When a high-profile investor places big bets in AI leaders, markets take notice. This piece breaks down the latest mo...
A little-known rival to SCHD has delivered competitive long-run gains and steady monthly income, thanks to a mid-cap ...